Open AccessPositive correlation of serum angiopoietin-like protein 3 levels with metabolic syndrome in patients with coronary artery disease
Author(s) -
Shao-Leon Lian,
BangGee Hsu,
JiHung Wang,
Ming-Chun Chen
Publication year - 2022
Publication title -
tzu-chi medical journal/cí-jì yīxué
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.343
H-Index - 15
eISSN - 2223-8956
pISSN - 1016-3190
DOI - 10.4103/tcmj.tcmj_49_21
Subject(s) - medicine , metabolic syndrome , endocrinology , coronary artery disease , odds ratio , insulin resistance , waist , body mass index , diabetes mellitus , triglyceride , blood pressure , gastroenterology , insulin , cholesterol
Angiopoietin-like protein 3 (ANGPTL3) regulates triglyceride metabolism by reversibly inhibiting the lipoprotein lipase activity. Metabolic syndrome (MetS) is an independent risk factor for further cardiovascular disease. This study evaluated the relationship between the fasting serum ANGPTL3 levels and MetS in patients with coronary artery disease (CAD).